| For: | Ascha M, Wang Z, Ascha MS, Dweik R, Zein NN, Grove D, Brown JM, Marshall S, Lopez R, Hanouneh IA. Metabolomics studies identify novel diagnostic and prognostic indicators in patients with alcoholic hepatitis. World J Hepatol 2016; 8(10): 499-508 [PMID: 27057307 DOI: 10.4254/wjh.v8.i10.499] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v8/i10/499.htm |
| Number | Citing Articles |
| 1 |
Vinshi Khan, Nagireddy Putluri, Arun Sreekumar, Ayse L. Mindikoglu. Current Applications of Metabolomics in Cirrhosis. Metabolites 2018; 8(4) doi: 10.3390/metabo8040067
|
| 2 |
Mengqian Yu, Ying Zhu, Qingwei Cong, Chunyan Wu. Metabonomics Research Progress on Liver Diseases. Canadian Journal of Gastroenterology and Hepatology 2017; 2017 doi: 10.1155/2017/8467192
|
| 3 |
Robert N Helsley, Tatsunori Miyata, Anagha Kadam, Venkateshwari Varadharajan, Naseer Sangwan, Emily C Huang, Rakhee Banerjee, Amanda L Brown, Kevin K Fung, William J Massey, Chase Neumann, Danny Orabi, Lucas J Osborn, Rebecca C Schugar, Megan R McMullen, Annette Bellar, Kyle L Poulsen, Adam Kim, Vai Pathak, Marko Mrdjen, James T Anderson, Belinda Willard, Craig J McClain, Mack Mitchell, Arthur J McCullough, Svetlana Radaeva, Bruce Barton, Gyongyi Szabo, Srinivasan Dasarathy, Jose Carlos Garcia-Garcia, Daniel M Rotroff, Daniela S Allende, Zeneng Wang, Stanley L Hazen, Laura E Nagy, Jonathan Mark Brown. Gut microbial trimethylamine is elevated in alcohol-associated hepatitis and contributes to ethanol-induced liver injury in mice. eLife 2022; 11 doi: 10.7554/eLife.76554
|
| 4 |
Duoduo Lv, Ning Han, Hong Tang. Exploring potential associations between blood metabolites and cirrhosis risk: a Mendelian randomization and LC–MS/MS analysis. Frontiers in Medicine 2026; 13 doi: 10.3389/fmed.2026.1809188
|
| 5 |
Bogdan Procopet, Petra Fischer, Oana Farcau, Horia Stefanescu. Metabolomics: From liver chiromancy to personalized precision medicine in advanced chronic liver disease. World Journal of Hepatology 2018; 10(3): 371-378 doi: 10.4254/wjh.v10.i3.371
|
| 6 |
Hong Chang, Hong-yu Meng, Shu-min Liu, Yu Wang, Xiao-xu Yang, Fang Lu, Hong-yu Wang. Identification of key metabolic changes during liver fibrosis progression in rats using a urine and serum metabolomics approach. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-11759-z
|
| 7 |
Jian Sun, Yan Chen, Tao Wang, Waseem Ali, Yonggang Ma, Yan Yuan, Jianhong Gu, Jianchun Bian, Zongping Liu, Hui Zou. Baicalin and N-acetylcysteine regulate choline metabolism via TFAM to attenuate cadmium-induced liver fibrosis. Phytomedicine 2024; 125 doi: 10.1016/j.phymed.2024.155337
|
| 8 |
Zhenhua Ma, Xiaomei Wang, Peiyuan Yin, Ruihong Wu, Lina Zhou, Guowang Xu, Junqi Niu. Serum metabolome and targeted bile acid profiling reveals potential novel biomarkers for drug-induced liver injury. Medicine 2019; 98(31) doi: 10.1097/MD.0000000000016717
|
| 9 |
Kalpesh G. Patel, Nikolaos T. Pyrsopoulos. Microbiome and Metabolome in Diagnosis, Therapy, and other Strategic Applications. 2019; doi: 10.1016/B978-0-12-815249-2.00028-2
|
| 10 |
Annika Reintam Blaser, Martin Padar, Jonathan Tang, John Dutton, Alastair Forbes. Citrulline and intestinal fatty acid-binding protein as biomarkers for gastrointestinal dysfunction in the critically ill. Anaesthesiology Intensive Therapy 2019; 51(3) doi: 10.5114/ait.2019.86049
|
| 11 |
Marta Koperska, Drew D. Kiraly. Microbiome‐derived metabolites in substance use disorders: Mechanisms and implications. Annals of the New York Academy of Sciences 2025; 1551(1) doi: 10.1111/nyas.15416
|
| 12 |
Hui Li, Yan Wang, Shizhao Ma, Chaoqun Zhang, Hua Liu, Dianxing Sun. Clinical significance of small molecule metabolites in the blood of patients with different types of liver injury. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-91164-9
|
| 13 |
Preetpal Singh, Ravinder Singh, Chirag Pasricha, Pratima Kumari. Navigating liver health with metabolomics: A comprehensive review. Clinica Chimica Acta 2025; 566 doi: 10.1016/j.cca.2024.120038
|
| 14 |
Yarong Yang, Zexin Huang, Zhao Yang, Ying Qi, Hui Shi, Yifei Zhou, Fangyu Wang, Miaofang Yang. Serum metabolomic profiling reveals an increase in homocitrulline in Chinese patients with nonalcoholic fatty liver disease: a retrospective study. PeerJ 2021; 9 doi: 10.7717/peerj.11346
|
| 15 |
Joanna Matysiak, Agnieszka Klupczynska, Kacper Packi, Anna Mackowiak-Jakubowska, Anna Bręborowicz, Olga Pawlicka, Katarzyna Olejniczak, Zenon J. Kokot, Jan Matysiak. Alterations in Serum-Free Amino Acid Profiles in Childhood Asthma. International Journal of Environmental Research and Public Health 2020; 17(13) doi: 10.3390/ijerph17134758
|
| 16 |
Guo Lin, Ji-Hong Chen, Yu-Hang Yin, Hao-Nan Zhao, Zhuang Liu, Xing-Shun Qi. Application of metabolomics in liver cirrhosis and its complications. World Chinese Journal of Digestology 2024; 32(8) doi: 10.11569/wcjd.v32.i8.561
Abstract(622) |
Core Tip(578) |
Full Article(HTML)(3707)
|
Times Cited (0)
|
Total Visits (4115)
|
Open
|
| 17 |
Elizabeth L. Godfrey, Tahir H. Malik, Jennifer C. Lai, Ayse L. Mindikoglu, N. Thao N. Galván, Ronald T. Cotton, Christine A. O’Mahony, John A. Goss, Abbas Rana. The decreasing predictive power of MELD in an era of changing etiology of liver disease. American Journal of Transplantation 2019; 19(12) doi: 10.1111/ajt.15559
|
| 18 |
Oana A. Zeleznik, D. Bradley Welling, Konstantina Stankovic, Lisa Frueh, Raji Balasubramanian, Gary C. Curhan, Sharon G. Curhan. Association of Plasma Metabolomic Biomarkers With Persistent Tinnitus. JAMA Otolaryngology–Head & Neck Surgery 2023; 149(5) doi: 10.1001/jamaoto.2023.0052
|
| 19 |
A. Brianne Bota, John Graydon Simmons, Alicia DiBattista, Kumanan Wilson. Carnitine in Alcohol Use Disorders: A Scoping Review. Alcoholism: Clinical and Experimental Research 2021; 45(4) doi: 10.1111/acer.14568
|